MedPath

JAN WALEWSKI

🇵🇱Poland
Ownership
-
Employees
-
Market Cap
-
Website

Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma

Not Applicable
Completed
Conditions
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2009-07-10
Last Posted Date
2019-08-19
Lead Sponsor
Jan Walewski
Target Recruit Count
12
Registration Number
NCT00937183
Locations
🇵🇱

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology - Warsaw, Warsaw, Poland

© Copyright 2025. All Rights Reserved by MedPath